Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal ...
Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
In India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies ...
Pregnant patients in their third trimester and postpartum women showed higher risk for IPD compared with nonpregnant patients.
Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...
Hosted on MSN4d
How To Identify Pneumococcal Diseases In Kids?While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.
Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...
The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback